Pharmacokinetic-Pharmacodynamic Modeling of the Respiratory Depressant Effect of Norbuprenorphine in Rats

@article{Yassen2007PharmacokineticPharmacodynamicMO,
  title={Pharmacokinetic-Pharmacodynamic Modeling of the Respiratory Depressant Effect of Norbuprenorphine in Rats},
  author={A. Yassen and Jingmin Kan and E. Olofsen and E. Suidgeest and A. Dahan and M. Danhof},
  journal={Journal of Pharmacology and Experimental Therapeutics},
  year={2007},
  volume={321},
  pages={598 - 607}
}
  • A. Yassen, Jingmin Kan, +3 authors M. Danhof
  • Published 2007
  • Medicine, Chemistry
  • Journal of Pharmacology and Experimental Therapeutics
    • The objective of this investigation was to characterize the pharmacokinetic-pharmacodynamic (PK-PD) correlation of buprenorphine's active metabolite norbuprenorphine for the effect on respiration in rats. Following i.v. administration in rats (dose range 0.32–1.848 mg), the time course of the concentration in plasma was determined in conjunction with the effect in ventilation as determined with a novel whole-body plethysmography technique. The PK of norbuprenorphine was best described by a… CONTINUE READING
    View on ASPET
    jpet.aspetjournals.org
    29 Citations
    Highly Influencial Citations
    1
    Background Citations
    11
    Results Citations
    1
    29 Citations
    Citation Type

    Citation Type

    Pharmacokinetic and pharmacodynamic modelling after subcutaneous, intravenous and buccal administration of a high-concentration formulation of buprenorphine in conscious cats
    • 10
    • PDF
    Incorporating receptor theory in mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling.
    • 77
    Pharmacokinetic and pharmacodynamic analysis in anesthesia : a modeling odyssey
    Reduced Pupil Diameter in Volunteers on Stable Buprenorphine Maintenance Therapy with Telaprevir: a Drug-Drug Interaction Involving P-Glycoprotein at the Blood-Brain Barrier?
    • 3
    • PDF
    Pregnancy Increases Norbuprenorphine Clearance in Mice by Induction of Hepatic Glucuronidation
    • 3
    • PDF
    Mechanism-based pharmacodynamic modeling.
    • 39
    P-Glycoprotein Is a Major Determinant of Norbuprenorphine Brain Exposure and Antinociception
    • 44
    • PDF
    In Utero Exposure to Norbuprenorphine, a Major Metabolite of Buprenorphine, Induces Fetal Opioid Dependence and Leads to Neonatal Opioid Withdrawal Syndrome
    • 4
    • Highly Influenced
    • PDF
    Reduced Pupil Diameter in Volunteers on Stable Buprenorphine Maintenance Therapy with Telaprevir: a Drug-Drug Interaction Involving P-Glycoprotein at the Blood-Brain Barrier? L
    Buprenorphine metabolites, buprenorphine-3-glucuronide and norbuprenorphine-3-glucuronide, are biologically active.
    • 92
    • PDF

    References

    SHOWING 1-10 OF 58 REFERENCES
    Mechanism-Based Pharmacokinetic-Pharmacodynamic Modeling of the Respiratory-Depressant Effect of Buprenorphine and Fentanyl in Rats
    • 40
    • PDF
    Pharmacokinetic-Pharmacodynamic Modeling of the Antinociceptive Effect of Buprenorphine and Fentanyl in Rats: Role of Receptor Equilibration Kinetics
    • 97
    • PDF
    Mechanism‐based PK/PD Modeling of the Respiratory Depressant Effect of Buprenorphine and Fentanyl in Healthy Volunteers
    • 78
    The comparative pharmacodynamics of remifentanil and its metabolite, GR90291, in a rat electroencephalographic model.
    • 63
    Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine.
    • 622
    Characterization of the pharmacokinetics of buprenorphine and norbuprenorphine in rats after intravenous bolus administration of buprenorphine.
    • S. Gopal, T. Tzeng, A. Cowan
    • Chemistry, Medicine
    • European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
    • 2002
    • 43
    • Highly Influential
    Kinetics of respiratory depression in rats induced by buprenorphine and its metabolite, norbuprenorphine.
    • 120
    • PDF
    Buprenorphine is protective against the depressive effects of norbuprenorphine on ventilation.
    • 57
    Pharmacokinetic analysis of enterohepatic circulation of buprenorphine and its active metabolite, norbuprenorphine, in rats.
    • 66
    Clinical actions of fentanyl and buprenorphine. The significance of receptor binding.
    • 194
    • PDF